Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America

AIDS

Volumn 29, Issue 2, 2015, Pages 221-229

  Helleberg, Marie ^a,b   May, Margaret T ^c   Ingle, Suzanne M ^c   Dabis, Francois ^d   Reiss, Peter ^e   Fätkenheuer, Gerd ^f   Costagliola, Dominique ^g,h   D'Arminio, Antonella ⁱ   Cavassini, Matthias ^j   Smith, Colette ^k   Justice, Amy C ^l,m   Gill, John ⁿ   Sterne, Jonathan A C ^c   Obela, Niels ^a,b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF COLOGNE   (Germany)

^g SORBONNE UNIVERSITÉ   (France)

^h INSTITUT PIERRE LOUIS D EPIDÉMIOLOGIE ET DE SANTÉ PUBLIQUE   (France)

ⁱ UNIVERSITY OF MILAN   (Italy)

^j LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^k UNIVERSITY COLLEGE LONDON   (United Kingdom)

^l YALE UNIVERSITY   (United States)

^m VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

ⁿ UNIVERSITY OF CALGARY   (Canada)

more..

Author keywords

HIV; Life expectancy; Mortality; Non AIDS related mortality; Smoking; Tobacco

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; EUROPEAN; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; LIFE EXPECTANCY; LIFE TABLE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORTH AMERICA; NORTH AMERICAN; SMOKING; WESTERN EUROPE; CD4 LYMPHOCYTE COUNT; EPIDEMIOLOGY; EUROPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; MIDDLE AGED; TRENDS;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; EUROPE; FEMALE; HIV INFECTIONS; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; NORTH AMERICA; SMOKING;

EID: 84920269073     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000540     Document Type: Article

References (33)

1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2224-2260.
2. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
3. Vittinghoff E, Scheer S, O'Malley P, Colfax G, Holmberg SD, Buchbinder SP. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. J Infect Dis 1999;179:717-720.
4. Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med 2006;145:397-406.
5. Hasse B, Ledergerber B, Furrer H, Battegay M, Hirschel B, Cavassini M, et al. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2011;53:1130-1139.
6. Mocroft A, Reiss P, Gasiorowski J, Ledergerber B, Kowalska J, Chiesi A, et al. Serious fatal and nonfatal non-AIDS-defining illnesses in Europe. J Acquir Immune Defic Syndr 2010; 55:262-270.
7. Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 2010; 50:1387-1396.
8. Zwahlen M, Harris R, May M, Hogg R, Costagliola D, de Wolf F, et al. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. Int J Epidemiol 2009; 38:1624-1633.
9. Simmons R, Ciancio B, Kall M, Rice B, Delpech V. Ten-year mortality trends among persons diagnosed with HIV infection in England and Wales in the era of antiretroviral therapy: AIDS remains a silent killer. HIV Med 2013; 14:596-604.
10. Aberg JA. Aging, inflammation, and HIV infection. Top Antivir Med 2012; 20:101-105.
11. Lucas S. Causes of death in the HAART era. Curr Opin Infect Dis 2012; 25:36-41.
12. Helleberg M, Afzal S, Kronborg G, Larsen CS, Pedersen G, Pedersen C, et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis 2013; 56:727-734.
13. May MT, Ingle SM, Costagliola D, Justice AC, de Wolf F, Cavassini M, et al. Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC). Int J Epidemiol 2014; 43:691-702.
14. May M, Gompels M, Delpech V, Porter K, Post F, Johnson M, et al. Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. BMJ 2011; 343:d6016.
15. Nakagawa F, Lodwick RK, Smith CJ, Smith R, Cambiano V, Lundgren JD, et al. Projected life expectancy of people with HIV according to timing of diagnosis. AIDS 2012; 26:335-343.
16. Lewden C, Bouteloup V, de Wit S, Sabin C, Mocroft A, Wasmuth JC, et al. All-cause mortality in treated HIV-infected adults with CD4>/U 500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol 2012; 41:433-445.
17. Kowalska JD, Friis-Moller N, Kirk O, Bannister W, Mocroft A, Sabin C, et al. The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology. Epidemiology 2011; 22:516-523.
18. Lewden C, May T, Rosenthal E, Burty C, Bonnet F, Costagliola D, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: the 'Mortalite 2000 and 2005' surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr 2008; 48:590-598.
19. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008; 372:293-299.
20. World Health Organization. Global Health Observatory, Country statistics. 2014. Available from: http://www.who.int/gho/countries/en/ [accessed 24 July 2014].
21. Tron L, Lert F, Spire B, Dray-Spira R. Tobacco smoking in HIVinfected versus general population in France: heterogeneity across the various groups of people living with HIV. PLoS One 2014; 9:e107451.
22. Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE. Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav 2010; 14:824-835.
23. Lifson AR, Neuhaus J, Arribas JR, Berg-Wolf M, Labriola AM, Read TR. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial. Am J Public Health 2010; 100:1896-1903.
24. Gellert C, Schottker B, Holleczek B, Stegmaier C, Muller H, Brenner H. Using rate advancement periods for communicating the benefits of quitting smoking to older smokers. Tob Control 2013; 22:227-230.
25. Petoumenos K, Worm S, Reiss P, de Wit S, D'Arminio MA, Sabin C, et al. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(M). HIV Med 2011; 12:412-421.
26. Huber M, Ledergerber B, Sauter R, Young J, Fehr J, Cusini A, et al. Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians. HIV Med 2012; 13:387-397.
27. Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sorensen HT, et al. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 2007; 146:87-95.
28. Galai N, Park LP, Wesch J, Visscher B, Riddler S, Margolick JB. Effect of smoking on the clinical progression of HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:451-458.
29. Survival and progression of HIV disease in women attending GUM/HIV clinics in Britain and Ireland. Study Group for the MRC Collaborative Study of HIV Infection in Women. Sex Transm Infect 1999; 75:247-252.
30. Burns DN, Hillman D, Neaton JD, Sherer R, Mitchell T, Capps L, et al. Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13:374-383.
31. Crothers K, Goulet JL, Rodriguez-Barradas MC, Gibert CL, Oursler KA, Goetz MB, et al. Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans. AIDS Educ Prev 2009; 21 (Suppl 3):40-53.
32. Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts DH, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. Am J Public Health 2006; 96:1060-1065.
33. Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013; 368:341-350.